secwatch.observer — SEC 8-K summary
======================================

Issuer:     ABVC BIOPHARMA, INC. (ABVC)
CIK:        0001173313
Form:       8-K
Filed at:   2023-07-27T23:59:59+00:00
Accession:  0001213900-23-060140
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ABVC BioPharma prices $1.75M registered direct offering of 500,000 shares/pre-funded warrants at $3.50/share
--------------------------------------------------------------------------------

- Gross proceeds of $1.75M from sale of 300,000 shares and 200,000 pre-funded warrants at $3.50/share.
- Single institutional investor; closing expected July 31, 2023.
- Net proceeds for R&D, working capital, and possible debt repayment.
- Wilmington Capital Securities acting as exclusive placement agent.
- Offering made under effective shelf registration statement (File No. 333-260588).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1173313/000121390023060140/0001213900-23-060140-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1173313/000121390023060140/ea182424-8k_abvcbio.htm
  HTML page:      https://secwatch.observer/filing/0001213900-23-060140

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer